BioMed Research International

BioMed Research International / 2014 / Article

Research Article | Open Access

Volume 2014 |Article ID 594287 | 14 pages | https://doi.org/10.1155/2014/594287

Transforming Growth Factor-Beta (TGF-β) Signaling in Paravertebral Muscles in Juvenile and Adolescent Idiopathic Scoliosis

Academic Editor: Andre Van Wijnen
Received06 Apr 2014
Revised19 Jul 2014
Accepted20 Aug 2014
Published15 Sep 2014

Abstract

Most researchers agree that idiopathic scoliosis (IS) is a multifactorial disease influenced by complex genetic and environmental factors. The onset of the spinal deformity that determines the natural course of the disease, usually occurs in the juvenile or adolescent period. Transforming growth factors β (TGF-βs) and their receptors, TGFBRs, may be considered as candidate genes related to IS susceptibility and natural history. This study explores the transcriptional profile of TGF-βs, TGFBRs, and TGF-β responsive genes in the paravertebral muscles of patients with juvenile and adolescent idiopathic scoliosis (JIS and AIS, resp.). Muscle specimens were harvested intraoperatively and grouped according to the side of the curve and the age of scoliosis onset. The results of microarray and qRT-PCR analysis confirmed significantly higher transcript abundances of TGF-β2, TGF-β3, and TGFBR2 in samples from the curve concavity of AIS patients, suggesting a difference in TGF-β signaling in the pathogenesis of juvenile and adolescent curves. Analysis of TGF-β responsive genes in the transcriptomes of patients with AIS suggested overrepresentation of the genes localized in the extracellular region of curve concavity: LTBP3, LTBP4, ITGB4, and ITGB5. This finding suggests the extracellular region of paravertebral muscles as an interesting target for future molecular research into AIS pathogenesis.

1. Introduction

Scoliosis is the most common spinal deformity in humans. Changes in spinal shape are three-dimensional and can be described as lateral curvature in the frontal plane, thoracic lordosis in the sagittal plane, and axial rotation in the horizontal plane. About 20% of scoliosis represent a phenotypic expression accompanying various pathologic conditions originating in almost every human tissue. The remaining 80% are idiopathic curves. Although the etiopathogenesis of idiopathic scoliosis (IS) is still unknown, there is an agreement about the multifactorial nature of this disorder [14]. A genetic model with two sets of genes, one responsible for the initiation and the other for the curve progression, well illustrates the multifactorial nature of IS. These genes could act separately or interact under the influence of diverse environmental and epigenetic factors [3, 5, 6]. The result of these complex interactions is the high heterogeneity of morphologic types, differences in the progression potential and the ages at presentation of the idiopathic curves. Paravertebral muscles play an essential role in the control of spinal stability [7, 8]. Imbalance of the paravertebral muscles could lead to biomechanical instability resulting in the development of a scoliotic curve. In addition, differences in progression among individuals may stem from divergence in muscle activation strategies or an inherent deficiency in structure and function of these muscles [9]. The Transforming growth factor-β (TGF-β) superfamily consists of a variety of cytokines expressed in many different tissues including skeletal muscles [10]. Expression of these molecules is linked to normal processes such as growth, differentiation, regeneration, and the stress response. TGF-β signaling is also required for cell regulation, angiogenesis, apoptosis, migration, extracellular matrix (ECM) remodeling and embryonic development [1012]. TGF-β1 is one of the candidate genes in osteoporosis, and decreased bone mineral density (BMD) was observed in 27–68% of children with IS [1318]. Osteopenia has also been suggested as one of the progression risk factors of IS [19, 20]. TGF-β1–3 isoforms are encoded by three different genes located respectively on chromosomes 19q13, 1q41, and 14q24 [11, 12]. Activated dimerized TGF-β proteins bind to cell-surface receptors type 1 and 2 (TGFBR1 and TGFBR2); transmembrane serine/threonine specific kinases that interact and phosphorylate intracellular molecules [21]. TGF-β ligands can also interact with the coreceptors endoglin and betaglycan, known as TGFBR3 [11]. Both endoglin and betaglycan can present TGF-βs to the TGFBR2 which then complexes with and phosphorylates TGFBR1 [21]. TGFBR3 is especially important for the TGF-β2 isoform, which, because of its low affinity, requires the presence of TGFBR3 to form a complex with TGFBR2 [22, 23]. Intracellular signaling of TGF-βs is mediated by proteins of Smads family. Smads 2 and 3 are substrates for receptors activated by TGF-βs and activins. Smads 1, 5, and 8 are downstream effectors for receptors activated by BMPs, GDFs, and MIFs. Phosphorylated Smads 1, 2, 3, 5, and 8 associate with Smad 4 and these complexes translocate to the nucleus, where together with other transcription factors they regulate the transcription of target genes [11, 24]. In addition to the canonical Smad pathway TGF-βs also signal through noncanonical pathways including mitogen activated kinase (MAPK), nuclear factor κ-B (NF-κ-B), Rho-like GTPase, phosphoinositide 3-kinase (PI3K)/Akt, hypoxia/hypoxia-inducible factor-1 (HIF-1) pathways [10, 11, 25]. Abnormalities in TGF-β signaling play an important role in various inherited and acquired musculoskeletal disorders where scoliotic deformity of the axial skeleton is one of the important clinical features. Progressive scoliosis occurs in approximately 45 to 60% of patients with Marfan syndrome (MFS) [26]. MFS is an autosomal dominant systemic disorder of connective tissue, caused by mutation of the FBN1 gene, which encodes extracellular matrix protein fibrillin-1 [10]. Fibrillin-1 stabilizes the Latent TGF-β complexes in the extracellular matrix. The various symptoms of Marfan syndrome are considered to be the result of an overall abnormality in the homeostasis of the extracellular matrix in which mutated forms of fibrillin-1 have led to alterations in mechanical properties of tissues, increased TGF-β signaling, and loss of appropriate cell-matrix interactions [24]. Marfan-like phenotypes may be also caused by mutations in TGF-β receptors. Scoliosis can be found in 46% of patients with Loeys-Dietz syndrome; a multisystem disease caused by a mutation in the genes encoding TGFBR1 or TGFBR2 [27]. Mutations of the gene encoding the TGF-β1 protein cause Camurati-Engelmann disease, which is associated with marfanoid habitus and increased TGF-β signaling, despite the absence of connective tissue fragility [28]. Increased TGF-β activity is also involved in the pathogenesis of muscular dystrophies characterized by variable progressive muscle weakness and wasting. In the most common form, Duchenne muscular dystrophy (DMD) mutations in the dystrophin gene lead to the loss of protection from contraction-induced injury. The resulting myocyte necrosis increases TGF-β signaling, which promotes muscle fibrosis at the expense of regeneration by satellite cells [29, 30]. Patients with DMD have a 90% chance of developing significant progressive scoliosis [31]. Despite many decades of multidisciplinary research, the cause(s) of IS remains unknown. The rapidly evolving arsenal of diagnostic and research tools offered by contemporary science allowed us to not only investigate 3-D deformity of IS not only through the radiological prism to determine changes in the spinal shape, but also to make an attempt at evaluating IS at the molecular level. In the last decade the number of studies investigating the molecular basis of IS has greatly increased. Much of the research work has focused on the identification of candidate genes related to connective tissue structure, bone formation and metabolism, melatonin signaling, puberty and growth, and axon guidance pathways [32]. Recently, in a case-control study, functional polymorphisms of the TGF-β1 gene were reported to be significantly associated with AIS susceptibility. In the female population, TGF-β1 polymorphism also appeared to be associated with the age of disease onset and curve severity [33]. Most of idiopathic scoliotic curves are diagnosed during the juvenile or adolescent period [34]. The age of scoliosis onset determines its epidemiology, natural course and response to the treatment to a large extent [3538]. Juvenile curves represent 12–21% of all scoliosis with unknown etiology [17, 35, 36, 39]. Curve morphologies are similar in both types of scoliosis, with the predomination of right primary thoracic and double primary thoracolumbar curves [37, 39]. The risk of deformity progression is the most important factor discriminating the juvenile type from the adolescent type of scoliosis. Patients with juvenile curves more often present with severe progression and 27% to 80% require operative treatment. In AIS, the risk of progression is much lower and only 0,1% of patients are operated on [3538, 40, 41]. The reason(s) for different ages of scoliosis onset and associated differences in natural history are unknown. The results of a heritability study of 69 extended families in Utah with a history of AIS show that the onset of AIS is inherited separately from curve pattern and severity [42]. It also seems that genetic markers of progression in the adolescent type do not apply to idiopathic scoliosis with an early onset, below 9 years of age [43]. IS is presumed to be a multifactorial disease that is influenced by complex genetic and environmental factors. It is likely that curves with an earlier onset may have a different genetic background to curves appearing in adolescence. TGF-βs and their receptors may be included in the group of candidate genes involved in the etiology and pathogenesis of IS. Changes in the transcriptional profile of TGF-βs and their receptors (TGFBRs) could affect the expression of TGF-β responsive genes [44]. This could influence the regulation of a variety of signal transduction pathways potentially involved in IS etiopathogenesis. This involvement of TGF-β signaling could differ in juvenile and adolescent types of IS. Although TGF-βs and their receptors may be considered as candidate genes potentially related to IS susceptibility and natural history, so far nothing is known about the expression of these genes in the muscular tissue of IS patients. Therefore, the main aims of this study were.(1)Evaluation of the transcriptional activity of TGF-β1, TGF-β2, and TGF-β3 and their receptors TGFBR1, TGFBR2, and TGFBR3, in paravertebral muscles on both sides of the scoliotic curve in JIS and AIS.(2)Identification of the TGF-β responsive genes differentiating between the concave and convex sides of the scoliotic curve in juvenile and adolescent idiopathic scoliosis.

2. Materials and Methods

2.1. Material

The study design was approved by the Bioethical Committee Board of Silesian Medical University. Informed, written consent was obtained from each patient participating in the study and if required from their parents. Nine female patients average age 17.9 (13.4 to 25 years old), with a definite diagnosis of IS were included in the study. Five of the girls had a scoliotic curve diagnosed before the age of 10, and were designated as group A—juvenile idiopathic scoliosis, and four after 10 years of age, designated as group B—Adolescent Idiopathic Scoliosis. All of the patients had undergone posterior corrective surgery by the C-D method. According to the Lenke classification two curves were of type 2, four curves of type 3, two curves of type 5, one of type 6 [45]. Preoperatively, the average frontal and sagittal Cobb angles measured on standard p-a, and lateral radiograms were 67.3° (range 36°–94°) and 37° (range 20°–55°), respectively. Axial plane deformity was measured on computed tomography (CT) scans performed at the curve apex by spinal rotation angle relative to the sagittal plane (RAsag) and rib hump index (RHi), as described by Aaro and Dahlborn [46]. The mean RAsag was 19° (range 2.5°–36°) and RHi was 0.41 (range 0.03–0.74). Eighteen paravertebral tissue samples were collected intraoperatively; 9 from the concave (M1) and 9 from the convex (M2) side of the curve apex. One sample from concave and one sample from convex side of the curve were lost for further investigation in each of the studied groups (4 samples). Details of the participants in each of the studied group are listed in Table 1.


PatientSampleGroupLenke typeCobb angleKyphosis angleRAsagRHindex

K.P.M2A36833140.48
F.J.M1, M2A39450240.56
B.P.M1A636482.50.03
R.K.M1, M2A26034170.36
N.M.M1, M2A5753021.50.5
M.S.M1B3663060.03
J.K.M2B28855290.64
P.A.M1, M2B54240210.3
W.P.M1, M2B37720360.7

2.2. Molecular Analysis

Fourteen total RNA samples were submitted for gene expression analysis to determine the expression of TGF-β isoforms and their receptors TGFBRs with the use of HGU 133A oligonucleotide microarrays (Affymetrix) and qRT-PCR. Microarray data were further analyzed to identify TGF-β responsive genes differentially expressed between the concave and the convex sides of the curve in group A-JIS and group B-AIS. Extraction of total RNA from paravertebral muscles tissue samples was performed as described in a previous study [47]. Total RNA served as a matrix for microarray and qRT-PCR analysis of 14 transcriptomes. Muscular tissue samples preparation and HGU 133A microarray processing was performed according to Affymetrix Gene Expression Analysis Technical Manual. Details of the microarray processing were described previously [47]. Every step of the paravertebral muscle transcriptome processing method was verified qualitatively by electrophoresis on a 1% agarose gel stained with ethidium bromide and quantitatively by absorbance at 260 nm using a Gene Quant II spectrophotometer (Pharmacia LKB Biochrom Ltd.). After hybridization, fluorescence intensity was measured with an Agilent Gene Array Scanner G2500A (Affymetrix). After the microarrays were deemed suitable for comparative analysis, the fluorescence intensity values of all 22 843 transcripts of the 14 HG U133A chips were simultaneously normalized with the use of robust multichip average (RMA) algorithm [48]. The first step of the microarray analysis relied on a comparison of the fluorescence signals intensities of 10 mRNA IDs complementary to HGU 133A microarray probes between the paravertebral muscles of the concave and the convex side of the curve in JIS and AIS: three for TGF-β2, two for TGF-β1, two for TGFBR2, and one for each of TGF-β3, TGFBR1, and TGFBR3. The results of the microarray experiment were validated by qRT-PCR. Total RNA extracted from 14 paravertebral tissue samples served as a matrix for qRT-PCR of TGF-β1, TGF-β2, TGF-β3 mRNA and that of their receptors: TGFBR1, TGFBR2, and TGFBR3. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and β-actin (ACTB) mRNA served as endogenous controls. The quantitative analysis was carried out with the use of a Sequence Detector ABI PRISM 7000 (Applied Biosystems). A standard curve was constructed for standards of ACTB (TaqMan DNA Template Reagents Kit, Applied Biosystems) and mRNA abundance in all tissue specimens was expressed as mRNA copy number per 1 μg of total RNA. Details of the qRT-PCR method and the sequence of PCR primers were described in previous studies [49, 50].

Statistical analysis of the microarray results was performed with a GeneSpring 11 GX application (Agilent Technologies). Statistical analysis of the qRT-PCR results was performed with Statistica Version 10 software (StatSoft). Quantitative data were compared using a two-way ANOVA, and a nonparametric Mann Whitney test, and was considered statistically significant. Selected differentiating genes were classified by their gene ontology (GO) and analyzed statistically with the use of an overrepresentation test in a web-based, open access PANTHER database [51].

The microarray data from this experiment are publically available in MIAME-compliant format from the following address: http://www.ebi.ac.uk/arrayexpress/, the file ID is E-MTAB-980.

3. Results

Paravertebral muscles transcriptomes were grouped according to the side of the curve (M1—curve concavity, M2—curve convexity) and the age of scoliosis onset (A-juvenile idiopathic scoliosis, B-adolescent idiopathic scoliosis). Differentiation of the transcriptomes was evaluated in three steps. In the first step, TGF-βs and TGFBRs mRNA IDs were differentiated by oligonucleotide microarray chips HGU 133A (Affymetrix). In the second step, the microarray results were validated of the by qRT-PCR. Finally, 1050 mRNA IDs of 530 genes connected with TGF-β biological activity were selected based on Affymetrix data, and analysis of the expression profile of their transcriptomes was performed with the microarray data in order to select candidate genes differentiating paravertebral muscles from curve concavity and convexity in JIS and AIS.

3.1. Evaluation of TGF-βs and TGFBRs Expression in the Paravertebral Muscles of JIS and AIS Patients Using HG U133A Microarrays

Preliminary assessment of the mRNA fluorescence signal dispersion of the analyzed transcripts was performed with a heat map generated in GeneSpring 11 GX application. The heat map displays the normalized signal values, permitting the comparison of the transcriptional activity of the TGF-βs and TGFBRs in relation to the average transcriptional activity of paravertebral muscles. The expression value of each gene is mapped to a color-intensity value. Yellow indicates an average level of specific mRNA abundance in the analyzed transcriptomes. An increase in the mRNA abundance compared to the average value correlates with a change towards the red colors and decrease with a change towards the blue. Differentiation of the colors seen on the generated heat map indicates that transcriptional profile of the analyzed samples changes with the age of scoliosis onset (group A and B) and the side of the scoliotic curve (M1 and M2), as shown in Figure 1. Subsequent fold change analysis of differences in expression between the analyzed mRNA groups was performed with a nonparametric Mann-Whitney test with permutative -value computation. A fold change with a cutoff ≥ 1.1 and was assumed to be statistically significant (Table 2).


GroupIDSymbolNCBI-IDMann-WhitneyFCRegulation

A (M1 versus M2)203085_s_atTGF-17040NS1.3Up
204731_atTGFBR37049NS1.1Up
206943_atTGFBR17046NS1.1Down
209908_s_atTGF-27042NS1.1Down

B (M1 versus M2)207334_s_atTGFBR270480.0091.1Up
209747_atTGF-370430.0141.1Up
209908_s_atTGF-270420.0161.2Up

Statistically significant differences in fluorescence signal intensity between the concave and convex paravertebral muscle transcriptomes were found for TGF-β2, TGF-β3 and TGFBR2 mRNA probes only in group B-AIS.

3.2. qRT-PCR Evaluation of the Transcriptional Profile of TGF-βs and TGFBRs in Paravertebral Muscles of JIS and AIS Patients

qRT-PCR was used to evaluate the transcriptional profile of TGF-β1–3 and their receptors, TGFBR1–3 in the paravertebral muscles of patients with JIS and AIS. The abundance of TGF-βs and TGFBRs mRNA in the concave (M1) and convex (M2) sides of the curve in groups A and B confirmed the results of the HGU 133A microarray experiment. Significantly higher abundances of TGF-β2, TGF-β3 and TGFBR2 mRNA (nonparametric Mann-Whitney test, ) on the concave side of the curve were found in group B. In group A, a statistically significant difference in the abundance of TGFBR3 mRNA was found, however, this was not confirmed by the preceding microarray experiment (Table 3, Figure 2).


Group value nonparametric Mann-Whitney test
TGF-1TGF-2TGF-3TGFBR1TGFBR2TGFBR3

A (M1 versus M2)0.4920.9580.3130.5620.6830.022
B (M1 versus M2)0.6830.00440.0480.1570.01090.214

3.3. Transcriptional Profile of TGF-β Responsive Genes

Differences in the expression of TGF-β responsive genes between the paravertebral muscles of the concave and convex sides of the curve were evaluated in groups A and B. 1050 mRNA IDs of TGFβ-associated genes were selected from 22843 transcripts that could be analyzed with HGU 133A chips [52]. A matrix plot of normalized log-intensities was used to visualize the degree of difference in TGF-β responsive genes between muscular tissue transcriptomes harvested from curve concavity and convexity in both groups. The main purpose of the matrix plot is to obtain an overview of the correlation between conditions in the dataset and detect conditions that separate the data into different groups. Higher intersample differences are interpreted through the distance of the spots from the regression line. Matrix plot analysis of the expression data highlighted a greater number of up- and downregulated genes in the paravertebral muscles of group A (AM1 versus AM2) compared to group B, where these differences were less pronounced. The matrix plot generated also indicates greater differences in TGF-β responsive gene expression at the mRNA level between groups A and B in the specimens from the curve concavity (AM1 versus BM1). The difference was much less clear between the transcriptomes from the curve convexity (AM2 versus BM2—Figure 3).

Further statistical analysis of the microarray data was performed by means of two-way ANOVA to test the main effects of the curve side (M1, M2), and age of scoliosis onset (A, B), and their interactions. Through this analysis, 144 genes were identified as having significantly different expression either with respect to the of the curve side, the age of scoliosis onset, or both. The Venn diagram in Figure 4 displays the numbers of these genes products whose values were influenced by each parameter independently (side of the curve and age of scoliosis onset) and also by the effect that each of the parameters had on the other. From a total of 45 genes that displayed a curve side main effect, 31 were significant due to the curve side effect only, while 4 genes displayed the curve side effect and an interaction effect. Expression of another 58 genes displayed an age of scoliosis onset effect. Of those, 8 were affected by both side of the curve and age of onset, but each of the factors affected gene expression independently one of another. In the case of 51 genes that were statistically significant neither with the regard to the side of the curve, nor to the age of scoliosis onset, the two-way ANOVA test had a value < 0.05 for the interaction effect. Nine genes were statistically significant for the age of onset effect and interaction effect but not the curve side effect. Four genes were statistically significant with regard to the side of the curve effect and interaction effect. Two genes displayed all the three effects: side of the curve, age of onset and interaction (Figure 4). Interaction effects indicate that there is no overall effect, but rather an effect that changes with the levels of another variable. As it is dangerous to interpret main effects when a gene shows an interaction effect, further statistical analyses were performed with nonparametric Mann-Whitney test, with permutative -value computation type (100 permutations). Fold change with a cutoff > 1 and was assumed to be statistically significant. In consequence, a group of 44 mRNA IDs of TGF-β related genes differentially expressed between M1 and M2 paravertebral muscles was selected from group A and 34 mRNA IDs from group B. Further selection of differentially expressed genes was performed by comparison of the results of the two-way ANOVA and nonparametric Mann-Whitney tests. Only those genes that fulfilled the criteria of statistical significance in both tests were considered for GO classification. A total of 24 genes (10 upregulated and 14 downregulated) differentiating paravertebral M1 and M2 transcriptomes were selected from group A and 11 genes (7 upregulated and 4 downregulated) from group B. Selected genes were subsequently classified by their GO molecular function through the open access PANTHER database (Table 4). Both lists of differentiating genes were subsequently divided into upregulated and downregulated groups and further analyzed statistically using an overrepresentation test; a binominal statistical tool that takes a list of genes and finds PANTHER functional classes that are overrepresented or underrepresented in the list compared with a selected reference list of genes [51]. Overrepresentation test analysis was performed in terms of GO molecular function, biological process and cellular component with the use of Bonferroni correction for multiple testing; was considered statistically significant. The reference list comprised 1050 mRNA IDs of 530 TGF-β related genes that were analyzed with HGU 133A microarray chips. This analysis revealed no statistically significant results in group A. In addition, in group B no statistically significant results were found neither in the group of downregulated genes nor in the group of upregulated genes in the GO category of biological process. However analysis of GO molecular function in the group of genes upregulated in group B showed statistically significant overrepresentation of genes connected with calmodulin binding (LTBP3, LTBP4, and MYL6; Figure 5). Analysis of the GO cellular component localization of the upregulated genes of the group B indicated statistically significant overrepresentation of genes localized in the extracellular matrix and extracellular region (LTBP3, LTBP4, ITGB4, and ITGB5), (Figure 6).


FunctionJISAIS
GeneFCRegulationGeneFCRegulation

Transcription factor activityNR3C10.041.56upTOX40.011.17down
SMAD30.021.18up
TRIM330.031.38down
ZBTB7B0.021.26down

Growth factor activityBMP2K0.041.12downGDF150.031.17up
BMP60.021.17down
INHBA0.011.18down

Receptor activityTACD20.021.22downITGB40.011.09up
ITGB50.011.15up

Calcium ion bindingFKBP1A0.011.37up
PCDH10.011.3down

Calmodulin bindingLTBP30.032.34up
LTBP40.011.5up
MYL60.031.53up

Protein bindingFBXL120.011.31up
ASPP10.021.23down

Hormone activityPTHR0.021.1down

Cysteine type peptidase activityUCHL50.031.56up

Oxidoreductase activityEGLN10.041.52up

Str. constituent of cytoskeletonKRT150.011.26down

Ubiquitin protein ligase activitySMURF10.031.04down

Nucleotide kinase activityMAGI20.021.2down

Transmembrane receptor protein-kinase activityTGFBR20.011.13up

UnclassifiedFA1750.021.26up
TTC170.041.21up
WIPI30.021.19up
TMEM10.031.1up
UNC450.031.43down
DCAF70.011.23down
SH3D210.011.19down
RAB250.011.13down
L1TD10.021.05down

4. Discussion

In two previous studies significantly higher expression of TGF-β1 was found on the concave side of the curve in the vertebral cartilaginous endplates and articular cartilages of the apical articular processes of AIS patients, suggesting that TGF-β1 is involved either as an etiological factor or a secondary change in the curve development [53, 54]. In the first part of this work, gene expression profiling was used in order to identify differences in the expression of TGF-βs and their receptors, TGFBRs, between both sides of the curve in the paravertebral muscles of juvenile and adolescent idiopathic scoliosis. Significantly higher abundances of TGF-β2, TGF-β3, and TGFBR2 transcripts were confirmed using both microarray and qRT-PCR techniques in muscular tissue samples collected from the curve concavity of AIS patients. The expression pattern of TGF-βs and their receptors was not previously examined in the paravertebral muscles of IS patients with different ages of deformity onset. Increased transcriptional activity of TGF-β2, TGF-β3, and TGFBR2 seen on the concave side of the curve in AIS patients might suggest the involvement of TGF-β signaling in the pathogenesis of scoliotic curves with later onset. However it should be pointed out that all of the tissue samples were harvested from patients with severe curves, long after the deformity onset. The selection of patients with severe idiopathic scoliosis curves for experimental groups can be problematic because such patients represent the extreme cases, and at the time of the study they are usually much older than, when the curve started to develop [4]. The average age of the deformity onset (diagnosis) in the JIS group was 7.2 years old and in AIS group 12.5. The average age of patients at the time of the operative treatment, when the tissue specimens were collected, was 17.9 years old. Thus it is possible that increased TGF-β signaling at the curve concavity was also present in the JIS group but earlier in the curve evolution. Differences in TGF-β2, TGF-β3 and TGFBR2 expression between JIS and AIS may need definitive confirmation by histological staining. Despite the similarity of their actions in vitro, each of the TGF-β isoforms appears to mediate a different set of actions in vivo. Knocking out TGF-β1, TGF-β2, and TGF-β3 in mice has shown no phenotypic overlap, indicating that these isoforms are functionally noncompensated [21, 23, 55]. The difference in the expression of TGF-β2, TGF-β3 and TGFBR2 observed between the sides of the curve in the AIS group may be a secondary phenomenon in the scoliosis progression, reflecting an increase in the extent of fibrotic changes to the curve concavity; as TGF-βs are considered critical regulators of physiological fibrogenesis and pathological fibrosis. TGF-β1 and TGF-β2 are potent profibrotic factors, whereas TGF-β3 reduces the fibrotic response. It seems that TGF-β2 is secreted only at the initial stage of fibrosis as an assistant factor to TGF-β1. The ratio TGF-β1/TGF-β3 is also of importance and might influence the progression of the fibrotic response [12, 56]. Stimulating cells with TGF-βs immediately leads to positive and negative changes in the expression of several hundred genes. Many of these gene responses depend on the cell type and other conditions affecting the cell at the time of TGF-β stimulation [57, 58]. The differences in the expression of TGF-β isoforms and their receptors observed in this study between the concave and convex sides of the curve may suggest different role of TGF-β signaling in juvenile and adolescent idiopathic curves. This could be reflected by differences in the transactivation of TGF-β responsive genes. Thus, in the second part of this work we analyzed paravertebral muscle transcriptomes from JIS and AIS individuals in order to identify the TGF-β responsive genes that are differentially expressed between the concave and convex sides of the curve. Statistical analysis of the expression profile of 1050 mRNA probes of 530 TGF-β responsive genes permitted the selection of 10 upregulated and 14 downregulated candidate genes in JIS and 7 upregulated and 4 downregulated genes in AIS. There was no overlap between differentially expressed TGF-β related genes in the JIS and AIS groups. This observation supports the idea of differences in the involvement of TGF-β signaling in paravertebral muscles of IS patients with different ages of onset. The results of the overrepresentation test were statistically significant only in the AIS group of upregulated genes for the categories of GO molecular function and GO cellular component. In the category of GO molecular function statistically significant overrepresentation of genes involved in calmodulin binding was revealed: Myosin light polypeptide 6 (MYL6), latent transforming growth factor beta binding protein 3 (LTBP3), and latent transforming growth factor β binding protein 4 (LTBP4). The significant overexpression of genes involved in calmodulin binding seems to be interesting in the context of some previous studies concerning IS. It has been shown that an increased calmodulin concentration in platelets is associated with progression of AIS [59, 60]. The platelet calmodulin changes were attributed to paravertebral muscle activity, and a role for calmodulin in the etiopathogenesis of IS as a systemic mediator of tissues with contractile properties was suggested [60]. In animal models of IS administration of tamoxifen, a calmodulin antagonist, appeared to decrease the magnitude and incidence of the deformity [61, 62]. Examination of paravertebral muscles of patients undergoing surgery for AIS revealed higher concentrations of calmodulin in muscle specimens of the curve convexity [63]. Myosin light polypeptide 6 is a smooth muscle and nonmuscle myosin light chain encoded by the MYL6 gene, located on chromosome 12q13.2. MYL6 protein is one of the two essential light chains of the actin-based motor protein complex of myosin. The functional roles of the essential light myosin chains in the smooth muscle are not fully understood. It is likely that these proteins affect the interaction between the two myosin heads when the regulatory light chains are phosphorylated [64, 65]. It has been suggested that the type of the essential myosin light chain influences the maximal shortening velocity in smooth muscles [66]. Expression of MYL6 in human skeletal muscles has been confirmed by microarray investigations [67]. The role of MYL6 upregulation observed in the paravertebral muscles of the curve concavity in the pathogenesis of the scoliotic deformity in the AIS group remains to be elucidated. The protein products of TGF-β1–3 genes are secreted from cells to the extracellular space and maintained in an inactive form in a complex with latency associated polypeptide (LAP) and latent TGF-β binding proteins (LTBPs) [21]. LTBPs are large glycoproteins structurally related to fibrillin. Through interactions with divergent proteins, LTBPs affect the bioavailability of TGF-βs and play an important structural role in elastic fibril and microfibril organization and function [23, 66, 68]. Four different LTBPs are known, of which LTBP3 binds all three TGF-β LAP isoforms with high affinity, whereas LTBP4 shows a weak binding capacity only for TGF-β1 LAP [23, 69]. LTBP3 can also associate with a pro-form of myostatin, a TGF-β-like hormone that regulates the size of skeletal muscles [23]. Larger back muscle volume at the concave side of the curve apex in AIS patients has been confirmed by MRI data [70]. LTBP4 is highly expressed in skeletal muscle and has been postulated to be a determinant of damage and fibrosis in muscle diseases [71]. Studies in humans and mice show that LTBP4 performs a functional role in promoting elastogenesis and in regulating TGF-β activity [68]. Integrity of the structures stabilizing the spine, including the paravertebral muscles, depends to a large degree on the constituents of the extracellular matrix and their response to biomechanical load. Immunohistochemical studies on ligamentum flavum specimens from patients with AIS revealed pathological changes in the elastic fibers of the microfibrils [26]. Defects in the elastic fiber system may result in spinal imbalance and lead to spinal deformity. Elastic proteins have been observed in spinal connective tissues as well as in the muscle and bone matrix of scoliotic patients [72]. The upregulation of LTBP3 and LTBP4 seen in this study may suggest that these proteins, as important ECM components, could play an important role in the pathogenesis of AIS. This was further supported by GO cellular component overrepresentation test results. Statistically significant overrepresentation of genes localized in the ECM and extracellular region was found. In addition to LTBP3 and LTBP4, statistical analysis highlighted two other upregulated genes that were differentially expressed in the concave and convex sides of the curve in the AIS group: integrin beta4 (ITGB4), and integrin beta5 (ITGB5). The ECM is a complex three-dimensional network of macromolecules secreted and deposited into the space surrounding cells [28]. The ECM regulates cell behavior by acting as a substrate for cell migration, modulating growth factor activity, transmitting signals and serving as a structural framework necessary for normal structural integrity [24, 73]. Integrins are heterodimeric transmembrane receptors that attach cells to the surrounding ECM and mediate both cell-cell and cell-ECM interactions. These proteins play a role in bidirectional signaling across the cell membrane in order to regulate cell adhesion, migration, and proliferation as well as differentiation and extracellular matrix remodeling. Additionally, integrins can modulate the signaling pathways of many growth factors, including TGF-βs [7478]. In humans, each of the 24 known integrins is composed of one of 18 alpha subunits and one of 8 beta subunits. Each subunit contains a large extracellular domain, a transmembrane region, and a cytoplasmic tail [77, 78]. The combination of subunits determines the specificity of integrins for ECM molecules [76, 79, 80]. The extracellular domains bind with ECM proteins such as fibronectin, laminin and collagen. The cytoplasmic domains of beta subunits interact with kinases such as focal adhesion kinase and Src kinase, adaptor molecules like talin and kindlin and the cytoskeleton (actin and microtubules) [77]. Integrins also act as mechanotransducers, which sense tension generated either by cytoskeletal elements or the ECM [75, 81, 82]. Such integrin-mediated mechanotransduction plays an important role in remodeling and functional adaptation of skeletal muscle tissue to ensure an optimal force transmission with muscle contraction [79, 82]. Integrin beta4 (ITGB4), and integrin beta5 (ITGB5) subunits are encoded by genes located respectively on chromosomes 17q25 and 3q21 [67]. ITGB4 tends to associate with integrin alpha6 subunit and is one of the highly selective receptors of laminin, a major structural component of the basement membranes of epithelial tissues [76, 83]. In contrast to the majority of integrins alpha6beta4 does not connect to the actin cytoskeleton but to the intermediate filament system [75, 83]. It appears that, besides its role in stable adhesion, integrin alpha6beta4 is upregulated in wound healing and can play the role of master regulator of the expression levels of the other integrins in the epidermis [84]. Recent studies show that in skeletal muscle, beta4 integrin marks interstitial progenitor cells that are distinct from satellite cells but exhibit myogenic potential [85, 86]. Integrin alphavbeta5 functions as a major vitronectin receptor and, to lesser extent, as a fibronectin receptor [76, 79]. TGF-β1 and TGF-β3 can be activated through their interaction with several integrins, including alphavbeta5 [74, 76, 78, 87]. Activation of TGF-β by alphavbeta5 could be important in pathological conditions, as illustrated by an increased expression of this integrin in the dermis of scleroderma patients [84]. Additionally, TGF-β activation by alphavbeta5 is important in pulmonary fibrosis [74]. Interestingly, alphavbeta5 is also a molecular marker for skeletal muscle mononuclear cells, including satellite and progenitor interstitial cells [79]. The upregulation of ITGB4 and ITGB5 observed in the paravertebral muscles of the curve concavity of AIS patients merits further investigation as this could lead to the disequilibrium between the two sides of the curve and could be involved in the pathogenesis of AIS. However caution should be taken when drawing definite conclusions about the role of ECM macromolecules in the evolution of scoliotic curves, due to the small number of specimens analyzed in this study and the lack of a control group. Our results may need validation in another population with larger sample size. The exact genetic mechanisms that contribute to spinal malformation in IS are still to be unraveled. Neuromuscular abnormalities, in conjunction with adverse mechanical environments, in which hormonal and other chemical factors act as regulators of skeletal muscle tone and function, are possible explanations for the pathogenesis of IS [88]. The interactions between different cell types of the neuromuscular system are mainly mediated by diffusible factors, many of which are growth factors like TGF-βs [89]. Further molecular research is needed to determine whether interactions between growth factor signaling pathways, such as the TGF-β pathway, and transcriptional regulatory networks lead to the initiation and progression of scoliotic deformities. At present, treatment of IS is focused on symptoms and involves bracing, and surgery in more severe cases. The identification of proteins and signaling pathways with significant asymmetry in expression pattern between concave and convex side of the curve could suggest new biomarkers of progression risk and aid in developing novel therapeutics to combat structural changes of the spine.

5. Conclusions

The transcriptional activity of TGF-β2, TGF-β3, and TGFBR2 and the expression profile of TGF-β responsive genes differ in paravertebral muscle transcriptomes depending on the age of scoliosis onset and the side of the scoliotic curve. This phenomenon could signify a different involvement of TGF-β signaling in the pathogenesis of juvenile and adolescent curves. Analysis of TGF-β responsive genes that differ in the concave and convex paravertebral muscle transcriptomes of AIS patients highlights the upregulation of genes localized in the extracellular region of the concave side of the curve (LTBP3, LTBP4, ITGB4, and ITGB5). This finding suggests that the extracellular region of paravertebral muscles is an interesting target for future molecular research on AIS pathogenesis.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Acknowledgment

The study was supported by Grant 2P05C07430 from State Committee for Scientific Research of Polish Ministry of Science and Higher Education.

References

  1. T. G. Lowe, M. Edgar, J. Y. Marguiles et al., “Current concepts review. Etiology of idiopathic scoliosis: current trends in research,” Journal of Bone and Joint Surgery, vol. 82, no. 8, pp. 1157–1168, 2000. View at: Google Scholar
  2. R. G. Burwell, P. H. Dangerfield, and B. J. C. Freeman, “Concepts on the pathogenesis of adolescent idiopathic scoliosis. Bone growth and mass, vertebral column, spinal cord, brain, skull, extra-spinal left-right skeletal length asymmetries, disproportions and molecular pathogenesis,” Studies in Health Technology and Informatics, vol. 135, pp. 3–52, 2008. View at: Google Scholar
  3. W. J. Wang, H. Y. Yeung, W. C.-W. Chu et al., “Top theories for the etiopathogenesis of adolescent idiopathic scoliosis,” Journal of Pediatric Orthopaedics, vol. 31, no. 1, pp. S14–S27, 2011. View at: Publisher Site | Google Scholar
  4. K. M. Bagnall, “Using a synthesis of the research literature related to the aetiology of adolescent idiopathic scoliosis to provide ideas on future directions for success,” Scoliosis, vol. 3, no. 1, article 5, 2008. View at: Publisher Site | Google Scholar
  5. J. C. Cheng, N. L. Tang, H. Yeung, and N. Miller, “Genetic association of complex traits,” Clinical Orthopaedics and Related Research, vol. 462, pp. 36–44, 2007. View at: Google Scholar
  6. J. P. S. Hermus, L. W. Van Rhijn, and A. Van Ooij, “Non-genetic expression of adolescent idiopathic scoliosis: a case report and review of the literature,” European Spine Journal, vol. 16, no. 3, pp. S338–S341, 2007. View at: Publisher Site | Google Scholar
  7. J. Cholewicki, M. M. Panjabi, and A. Khachatryan, “Stabilizing function of trunk flexor-extensor muscles around a neutral spine posture,” Spine, vol. 22, no. 19, pp. 2207–2212, 1997. View at: Publisher Site | Google Scholar
  8. A. T. Masi, J. L. Dorsch, and J. Cholewicki, “Are adolescent idiopathic scoliosis and ankylosing spondylitis counter-opposing conditions? A hypothesis on biomechanical contributions predisposing to these spinal disorders,” Clinical and Experimental Rheumatology, vol. 21, no. 5, pp. 573–580, 2003. View at: Google Scholar
  9. M. C. Hawes and J. P. O'Brien, “The transformation of spinal curvature into spinal deformity: pathological processes and implications for treatment,” Scoliosis, vol. 1, no. 1, article 3, 2006. View at: Publisher Site | Google Scholar
  10. T. N. Burks and R. D. Cohn, “Role of TGF-β signaling in inherited and acquired myopathies,” Skeletal Muscle, vol. 1, no. 1, article 19, 2011. View at: Publisher Site | Google Scholar
  11. J. F. S. Santibañez, M. Quintanilla, and C. Bernabeu, “TGF-β/TGF-β receptor system and its role in physiological and pathological conditions,” Clinical Science, vol. 121, no. 6, pp. 233–251, 2011. View at: Publisher Site | Google Scholar
  12. C.-G. Zhao, X.-J. He, B. Lu, H.-P. Li, and A.-J. Kang, “Increased expression of collagens, transforming growth factor-β1, and -β3 in gluteal muscle contracture,” BMC Musculoskeletal Disorders, vol. 11, article 15, 2010. View at: Publisher Site | Google Scholar
  13. F. Zhu, Y. Qiu, H. Y. Yeung, K. M. Lee, and C.-Y. J. Cheng, “Trabecular bone micro-architecture and bone mineral density in adolescent idiopathic and congenital scoliosis,” Orthopaedic Surgery, vol. 1, no. 1, pp. 78–83, 2009. View at: Publisher Site | Google Scholar
  14. J. C. Y. Cheng and X. Guo, “Osteopenia in adolescent idiopathic scoliosis: a primary problem or secondary to the spinal deformity?” Spine, vol. 22, no. 15, pp. 1716–1721, 1997. View at: Publisher Site | Google Scholar
  15. J. C. Y. Cheng, X. Guo, and A. H. L. Sher, “Persistent osteopenia in adolescent idiopathic scoliosis: a longitudinal follow-up study,” Spine, vol. 24, no. 12, pp. 1218–1222, 1999. View at: Publisher Site | Google Scholar
  16. J. C. Cheng, S. P. Tang, X. Guo, C. W. Chan, and L. Qin, “Osteopenia in adolescent idiopathic scoliosis: a histomorphometric study,” Spine, vol. 26, no. 3, pp. E19–23, 2001. View at: Google Scholar
  17. M. Sadat-Ali, A. Al-Othman, D. Bubshait, and D. Al-Dakheel, “Does scoliosis causes low bone mass? A comparative study between siblings,” European Spine Journal, vol. 17, no. 7, pp. 944–947, 2008. View at: Publisher Site | Google Scholar
  18. W. W. Park, K. T. Suh, J. I. Kim, S.-J. Kim, and J. S. Lee, “Decreased osteogenic differentiation of mesenchymal stem cells and reduced bone mineral density in patients with adolescent idiopathic scoliosis,” European Spine Journal, vol. 18, no. 12, pp. 1920–1926, 2009. View at: Publisher Site | Google Scholar
  19. V. W. Y. Hung, L. Qin, C. S. K. Cheung et al., “Osteopenia: a new prognostic factor of curve progression in adolescent idiopathic scoliosis,” Journal of Bone and Joint Surgery A, vol. 87, no. 12, pp. 2709–2716, 2005. View at: Publisher Site | Google Scholar
  20. W. T. K. Lee, C. S. K. Cheung, Y. K. Tse et al., “Association of osteopenia with curve severity in adolescent idiopathic scoliosis: a study of 919 girls,” Osteoporosis International, vol. 16, no. 12, pp. 1924–1932, 2005. View at: Publisher Site | Google Scholar
  21. K. C. Flanders, “Smad3 as a mediator of the fibrotic response,” International Journal of Experimental Pathology, vol. 85, no. 2, pp. 47–64, 2004. View at: Publisher Site | Google Scholar
  22. L. Fernandez, F. Sanz-Rodrigez, F. Blanc, C. Bernabeu, and B. Botella, “Hereditary hemorrhagic teleangiectasia, a vascular dysplasia affecting the TGFβ signaling pathway,” Clinical Medicine & Research, vol. 4, pp. 66–78, 2006. View at: Google Scholar
  23. K. Janssens, P. Dijke, S. Janssens, and W. van Hul, “Transforming growth factor-β1 to the bone,” Endocrine Reviews, vol. 26, no. 6, pp. 743–774, 2005. View at: Publisher Site | Google Scholar
  24. S. G. Velleman, J. Shin, X. Li, and Y. Song, “Review: the skeletal muscle extracellular matrix: possible roles in the regulation of muscle development and growth,” Canadian Journal of Animal Science, vol. 92, no. 1, pp. 1–10, 2012. View at: Publisher Site | Google Scholar
  25. C. J. Mann, E. Perdiguero, Y. Kharraz et al., “Aberrant repair and fibrosis development in skeletal muscle,” Skeletal Muscle, vol. 1, no. 1, article 21, 2011. View at: Publisher Site | Google Scholar
  26. N. Hadley-Miller, B. Mims, and D. M. Milewicz, “The potential role of the elastic fiber system in adolescent idiopathic scoliosis,” Journal of Bone and Joint Surgery A, vol. 76, no. 8, pp. 1193–1206, 1994. View at: Google Scholar
  27. G. Erkula, P. D. Sponseller, L. C. Paulsen et al., “Musculoskeletal findings of Loeys-Dietz syndrome,” The Journal of Bone & Joint Surgery, vol. 92, no. 9, pp. 1876–1883, 2010. View at: Publisher Site | Google Scholar
  28. T. Mizuguchi and N. Matsumoto, “Recent progress in genetics of Marfan syndrome and Marfan-associated disorders,” Journal of Human Genetics, vol. 52, no. 1, pp. 1–12, 2007. View at: Publisher Site | Google Scholar
  29. S. A. Vetrone, E. Montecino-Rodriguez, E. Kudryashova et al., “Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-β,” The Journal of Clinical Investigation, vol. 119, no. 6, pp. 1583–1594, 2009. View at: Publisher Site | Google Scholar
  30. J. A. Goldstein and E. M. McNally, “Mechanisms of muscle weakness in muscular dystrophy,” Journal of General Physiology, vol. 136, no. 1, pp. 29–34, 2010. View at: Publisher Site | Google Scholar
  31. K. Bushby, R. Finkel, D. J. Birnkrant et al., “Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care,” The Lancet Neurology, vol. 9, no. 2, pp. 177–189, 2010. View at: Publisher Site | Google Scholar
  32. K. F. Gorman, C. Julien, and A. Moreau, “The genetic epidemiology of idiopathic scoliosis,” European Spine Journal, vol. 21, no. 10, pp. 1905–1919, 2012. View at: Publisher Site | Google Scholar
  33. I. I. Ryzhkov, E. E. Borzilov, M. I. Churnosov, A. V. Ataman, A. A. Dedkov, and A. V. Polonikov, “Transforming growth factor beta 1 is a novel susceptibility gene for adolescent idiopathic scoliosis,” Spine, vol. 38, no. 12, pp. E699–E704, 2013. View at: Publisher Site | Google Scholar
  34. C. A. Wise, X. Gao, S. Shoemaker, D. Gordon, and J. A. Herring, “Understanding genetic factors in idiopathic scoliosis, a complex disease of childhood,” Current Genomics, vol. 9, no. 1, pp. 51–59, 2008. View at: Publisher Site | Google Scholar
  35. U. M. Figueiredo and J. I. James, “Juvenile idiopathic scoliosis,” Journal of Bone and Joint Surgery B, vol. 63, no. 1, pp. 61–66, 1981. View at: Google Scholar
  36. V. T. Tolo and R. Gillespie, “The characteristics of juvenile idiopathic scoliosis and results of its treatment,” Journal of Bone and Joint Surgery B, vol. 60, no. 2, pp. 181–188, 1978. View at: Google Scholar
  37. C. M. Robinson and M. J. McMaster, “Juvenile idiopathic scoliosis: curve patterns and prognosis in one hundred and nine patients,” Journal of Bone and Joint Surgery A, vol. 78, no. 8, pp. 1140–1148, 1996. View at: Google Scholar
  38. S. L. Weinstein, L. A. Dolan, K. F. Spratt, K. K. Peterson, M. J. Spoonamore, and I. V. Ponseti, “Health and Function of Patients with Untreated Idiopathic Scoliosis: a 50-Year Natural History Study,” Journal of the American Medical Association, vol. 289, no. 5, pp. 559–567, 2003. View at: Publisher Site | Google Scholar
  39. L. G. Lenke and M. B. Dobbs, “Management of juvenile idiopathic scoliosis,” Journal of Bone and Joint Surgery A, vol. 89, no. 1, pp. S55–S63, 2007. View at: Publisher Site | Google Scholar
  40. Y. P. Charles, J.-P. Daures, V. De Rosa, and A. Diméglio, “Progression risk of idiopathic juvenile scoliosis during pubertal growth,” Spine, vol. 31, no. 17, pp. 1933–1942, 2006. View at: Publisher Site | Google Scholar
  41. S. L. Weinstein, “Natural history,” Spine, vol. 24, no. 24, pp. 2592–2600, 1999. View at: Publisher Site | Google Scholar
  42. K. Ward, J. Ogilvie, V. Argyle et al., “Polygenic inheritance of adolescent idiopathic scoliosis: a study of extended families in Utah,” The American Journal of Medical Genetics A, vol. 152, no. 5, pp. 1178–1188, 2010. View at: Publisher Site | Google Scholar
  43. J. W. Ogilvie, “Update on prognostic genetic testing in adolescent idiopathic scoliosis (AIS),” Journal of Pediatric Orthopaedics, vol. 31, pp. S46–S48, 2011. View at: Publisher Site | Google Scholar
  44. J. Massagué, “How cells read TGF-β signals,” Nature Reviews Molecular Cell Biology, vol. 1, no. 3, pp. 169–178, 2000. View at: Publisher Site | Google Scholar
  45. L. G. Lenke, R. R. Betz, J. Harms et al., “Adolescent idiopathic scoliosis. A new classification to determine extent of spinal arthrodesis,” Journal of Bone and Joint Surgery A, vol. 83, no. 8, pp. 1169–1181, 2001. View at: Google Scholar
  46. S. Aaro and M. Dahlborn, “Estimation of vertebral rotation and the spinal and rib cage deformity in scoliosis by computer tomography,” Spine, vol. 6, no. 5, pp. 460–467, 1981. View at: Publisher Site | Google Scholar
  47. R. Nowak, J. Szota, and U. Mazurek, “Vitamin D Receptor gene (VDR) transcripts in bone, cartilage, muscles and blood and microarray analysis of vitamin D responsive genes expression in paravertebral muscles of Juvenile and Adolescent Idiopathic Scoliosis patients,” BMC Musculoskeletal Disorders, vol. 13, article 259, 2012. View at: Publisher Site | Google Scholar
  48. R. A. Irizarry, B. Hobbs, F. Collin et al., “Exploration, normalization, and summaries of high density oligonucleotide array probe level data,” Biostatistics, vol. 4, no. 2, pp. 249–264, 2003. View at: Publisher Site | Google Scholar
  49. B. Strzalka-Mrozik, A. Stanik-Walentek, M. Kapral et al., “Differential expression of transforming growth factor-β isoforms in bullous keratopathy corneas,” Molecular Vision, vol. 16, pp. 161–166, 2010, http://www.molvis.org/molvis/v16/a20. View at: Google Scholar
  50. W. Jachec, A. Foremny, D. Domal-Kwiatkowska et al., “Expression of TGF-β1 and its receptor genes (TβR I, TβR II, and TβR III-betaglycan) in peripheral blood leucocytes in patients with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome,” International Journal of Molecular Medicine, vol. 21, no. 1, pp. 99–107, 2008. View at: Google Scholar
  51. H. Mi, A. Muruganujan, and P. D. Thomas, “PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees,” Nucleic Acids Research, vol. 41, no. 1, pp. D377–D386, 2013. View at: Publisher Site | Google Scholar
  52. Affymetrix, https://www.affymetrix.com/analysis/netaffx/xmlquery.affx.
  53. H. Xu, G. Qiu, Z. Wu et al., “Expression of transforming growth factor and basic fibroblast growth factor and core protein of proteoglycan in human vertebral cartilaginous endplate of adolescent idiopathic scoliosis,” Spine, vol. 30, no. 17, pp. 1973–1978, 2005. View at: Publisher Site | Google Scholar
  54. G.-X. Qiu, Q.-Y. Li, Y. Liu et al., “Expression of transforming growth factor-β1 and basic fibroblast growth factor in articular process cartilages of adolescent idiopathic scoliosis,” Zhonghua Yi Xe Za Zhi, vol. 86, no. 21, pp. 1478–1483, 2006. View at: Google Scholar
  55. L. P. Sanford, I. Ormsby, A. C. Gittenberger-de Groot et al., “TGFβ2 knockout mice have multiple developmental defects that are non-overlapping with other TGFβ knockout phenotypes,” Development, vol. 124, no. 13, pp. 2659–2670, 1997. View at: Google Scholar
  56. A. Leask and D. J. Abraham, “TGF-β signaling and the fibrotic response,” The FASEB Journal, vol. 18, no. 7, pp. 816–827, 2004. View at: Publisher Site | Google Scholar
  57. J. Massagué and R. R. Gomis, “The logic of TGFβ signaling,” FEBS Letters, vol. 580, no. 12, pp. 2811–2820, 2006. View at: Publisher Site | Google Scholar
  58. R. Derynck and Y. E. Zhang, “Smad-dependent and Smad-independent pathways in TGF-β family signalling,” Nature, vol. 425, no. 6958, pp. 577–584, 2003. View at: Publisher Site | Google Scholar
  59. K. Kindsfater, T. Lowe, D. Lawellin, D. Weinstein, and J. Akmakjian, “Levels of platelet calmodulin for the prediction of progression and severity of adolescent idiopathic scoliosis,” Journal of Bone and Joint Surgery A, vol. 76, no. 8, pp. 1186–1192, 1994. View at: Google Scholar
  60. T. G. Lowe, R. G. Burwell, and P. H. Dangerfield, “Platelet calmodulin levels in adolescent idiopathic scoliosis (AIS): Can they predict curve progression and severity? Summary of an electronic focus group debate of the IBSE,” European Spine Journal, vol. 13, no. 3, pp. 257–265, 2004. View at: Publisher Site | Google Scholar
  61. I. Akel, G. DemirkIran, A. Alanay, S. Karahan, R. Marcucio, and E. Acaroglu, “The effect of calmodulin antagonists on scoliosis: bipedal C57BL/6 mice model,” European Spine Journal, vol. 18, no. 4, pp. 499–505, 2009. View at: Publisher Site | Google Scholar
  62. I. Akel, O. Kocak, G. Bozkurt, A. Alanay, R. Marcucio, and E. Acaroglu, “The effect of calmodulin antagonists on experimental scoliosis: a pinealectomized chicken model,” Spine, vol. 34, no. 6, pp. 533–538, 2009. View at: Publisher Site | Google Scholar
  63. E. Acaroglu, I. Akel, A. Alanay, M. Yazici, and R. Marcucio, “Comparison of the melatonin and calmodulin in paravertebral muscle and platelets of patients with or without adolescent idiopathic scoliosis,” Spine, vol. 34, no. 18, pp. E659–E663, 2009. View at: Publisher Site | Google Scholar
  64. O. Ogut and F. V. Brozovich, “Regulation of force in vascular smooth muscle,” Journal of Molecular and Cellular Cardiology, vol. 35, no. 4, pp. 347–355, 2003. View at: Publisher Site | Google Scholar
  65. A. Arner, M. Löfgren, and I. Morano, “Smooth, slow and smart muscle motors,” Journal of Muscle Research and Cell Motility, vol. 24, no. 2-3, pp. 165–173, 2003. View at: Publisher Site | Google Scholar
  66. U. Malmqvist and A. Arner, “Correlation between isoform composition of the 17 kDa myosin light chain and maximal shortening velocity in smooth muscle,” Pflügers Archiv, vol. 418, no. 6, pp. 523–530, 1991. View at: Publisher Site | Google Scholar
  67. The GeneCards Human Gene Database, http://www.genecards.org.
  68. V. Todorovic and D. B. Rifkin, “LTBPs, more than just an escort service,” Journal of Cellular Biochemistry, vol. 113, no. 2, pp. 410–418, 2012. View at: Publisher Site | Google Scholar
  69. J. J. Doyle, E. E. Gerber, and H. C. Dietz, “Matrix-dependent perturbation of TGFβ signaling and disease,” FEBS Letters, vol. 586, no. 14, pp. 2003–2015, 2012. View at: Publisher Site | Google Scholar
  70. G. Zoabli, P. A. Mathieu, and C.-É. Aubin, “Back muscles biometry in adolescent idiopathic scoliosis,” Spine Journal, vol. 7, no. 3, pp. 338–344, 2007. View at: Publisher Site | Google Scholar
  71. A. Heydemann, E. Ceco, J. E. Lim et al., “Latent TGF-β-binding protein 4 modifies muscular dystrophy in mice,” Journal of Clinical Investigation, vol. 119, no. 12, pp. 3703–3712, 2009. View at: Publisher Site | Google Scholar
  72. J. Yu, B. Li, J. Fairbank, and J. Urban, “Role of elastic fibers in scoliosis development: an immunohistochemical study of elastic proteins of spinal tissues,” Journal of Bone and Joint Surgery B, vol. 94, supplement 27, article 19, 2012. View at: Google Scholar
  73. R. Droguett, C. Cabello-Verrugio, C. Riquelme, and E. Brandan, “Extracellular proteoglycans modify TGF-β bio-availability attenuating its signaling during skeletal muscle differentiation,” Matrix Biology, vol. 25, no. 6, pp. 332–341, 2006. View at: Publisher Site | Google Scholar
  74. C. Margadant and A. Sonnenberg, “Integrin-TGF-β crosstalk in fibrosis, cancer and wound healing,” EMBO Reports, vol. 11, no. 2, pp. 97–105, 2010. View at: Publisher Site | Google Scholar
  75. M. Barczyk, S. Carracedo, and D. Gullberg, “Integrins,” Cell and Tissue Research, vol. 339, no. 1, pp. 269–280, 2010. View at: Publisher Site | Google Scholar
  76. J. D. Humphries, A. Byron, and M. J. Humphries, “Integrin ligands at a glance,” Journal of Cell Science, vol. 119, no. 19, pp. 3901–3903, 2006. View at: Publisher Site | Google Scholar
  77. R. Holmes and U. Rout, “Comparative studies of vertebrate beta integrin genes and proteins: ancient genes in vertebrate evolution,” Biomolecules, vol. 1, no. 1, pp. 3–31, 2011. View at: Publisher Site | Google Scholar
  78. J. S. Munger and D. Sheppard, “Cross talk among TGF-β signaling pathways, integrins, and the extracellular matrix,” Cold Spring Harbor Perspectives in Biology, vol. 3, no. 11, Article ID a005017, 2011. View at: Google Scholar
  79. A. C. M. Sinanan, J. R. A. Machell, G. T. Wynne-Hughest, N. P. Hunt, and M. P. Lewis, “αvβ3 and αvβ5 integrins and their role in muscle precursor cell adhesion,” Biology of the Cell, vol. 100, no. 8, pp. 465–477, 2008. View at: Publisher Site | Google Scholar
  80. U. Mayer, “Integrins: Redundant or important players in skeletal muscle?” Journal of Biological Chemistry, vol. 278, no. 17, pp. 14587–14590, 2003. View at: Publisher Site | Google Scholar
  81. P. Roca-Cusachs, T. Iskratsch, and M. P. Sheetz, “Finding the weakest link-exploring integrin-mediated mechanical molecular pathways,” Journal of Cell Science, vol. 125, no. 13, pp. 3025–3038, 2012. View at: Publisher Site | Google Scholar
  82. M. Kjær, “Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading,” Physiological Reviews, vol. 84, no. 2, pp. 649–698, 2004. View at: Publisher Site | Google Scholar
  83. D. Tsuruta, S. B. Hopkinson, K. D. Lane, M. E. Werner, V. L. Cryns, and J. C. R. Jones, “Crucial role of the specificity-determining loop of the integrin β4 subunit in the binding of cells to laminin-5 and outside-in signal transduction,” The Journal of Biological Chemistry, vol. 278, no. 40, pp. 38707–38714, 2003. View at: Publisher Site | Google Scholar
  84. K. R. Kligys, Y. Wu, S. B. Hopkinson, S. Kaur, L. C. Platanias, and J. C. R. Jones, “α6β4 integrin, a master regulator of expression of integrins in human keratinocytes,” The Journal of Biological Chemistry, vol. 287, no. 22, pp. 17975–17984, 2012. View at: Publisher Site | Google Scholar
  85. K. Liadaki, J. C. Casar, M. Wessen et al., “β4 integrin marks interstitial myogenic progenitor cells in adult murine skeletal muscle,” Journal of Histochemistry and Cytochemistry, vol. 60, no. 1, pp. 31–44, 2012. View at: Publisher Site | Google Scholar
  86. D. Sirabella, L. de Angelis, and L. Berghella, “Sources for skeletal muscle repair: from satellite cells to reprogramming,” Journal of Cachexia, Sarcopenia and Muscle, vol. 4, no. 2, pp. 125–136, 2013. View at: Publisher Site | Google Scholar
  87. M. Schwartz, “Integrins and extracellular matrix in mechanotransduction,” Cold Spring Harbor Perspectives in Biology, vol. 2, Article ID a005066, 2010. View at: Google Scholar
  88. E. Acaroglu, R. Bobe, J. Enouf, R. Marcucio, F. Moldovan, and A. Moreau, “The metabolic basis of adolescent idiopathic scoliosis: 2011 report of the “metabolic” workgroup of the Fondation Yves Cotrel,” European Spine Journal, vol. 21, no. 6, pp. 1033–1042, 2012. View at: Publisher Site | Google Scholar
  89. I. S. McLennan and K. Koishi, “The transforming growth factor-betas: multifaceted regulators of the development and maintenance of skeletal muscles, motoneurons and Schwann cells,” International Journal of Developmental Biology, vol. 46, no. 4, pp. 559–567, 2002. View at: Google Scholar

Copyright © 2014 Roman Nowak et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1357 Views | 571 Downloads | 8 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.